-+ 0.00%
-+ 0.00%
-+ 0.00%

AGENUS ANNOUNCES DATA FROM PHASE II STUDY OF BOT+BAL IN COMBINATION WITH AGENT-797 IN PD-1 REFRACTORY GASTROESOPHAGEAL CANCER TO BE PRESENTED AT AACR 2026

Reuters·04/03/2026 11:30:00

Please log in to view news